Search research articles
Contact Us
Filters
Showing results (31-40 of 173) with videos related to
Page
of 18
Sort By:
Journal of Chromatography
|
July 23, 1993
Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2
J A Awad, J D Morrow, L J Roberts
The Journal of Allergy and Clinical Immunology
|
May 1, 1994
Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation
J A Awad, J D Morrow, L J Roberts
Prostaglandins
|
February 1, 1997
A nomenclature system for the isoprostanes
D F Taber, J D Morrow, L J Roberts
American Journal of Hospital Pharmacy
|
June 1, 1990
Use of a database computer program to identify trends in reporting of adverse drug reactions
P E Johnston, J D Morrow, R A Branch
Analytical Biochemistry
|
January 1, 1990
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids
J D Morrow, T M Harris, L J Roberts
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners
|
July 4, 1998
Infants with Down syndrome: a look at temperament
C F Zickler, J D Morrow, M J Bull
Clinical Pharmacology and Therapeutics
|
April 1, 1995
Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo
C D Downard, L J Roberts, J D Morrow
Prostaglandins
|
October 1, 1994
Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor
A W Longmire, L J Roberts, J D Morrow
Journal of Biomedical Science
|
July 27, 1999
The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid
T Liu, A Stern, L J Roberts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions
C Gniwotta, J D Morrow, L J Roberts, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 173) with videos related to
Sort By:
Page
of 18
Journal of Chromatography
|
July 23, 1993
Simplification of the mass spectrometric assay for the major urinary metabolite of prostaglandin D2
J A Awad, J D Morrow, L J Roberts
The Journal of Allergy and Clinical Immunology
|
May 1, 1994
Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation
J A Awad, J D Morrow, L J Roberts
Prostaglandins
|
February 1, 1997
A nomenclature system for the isoprostanes
D F Taber, J D Morrow, L J Roberts
American Journal of Hospital Pharmacy
|
June 1, 1990
Use of a database computer program to identify trends in reporting of adverse drug reactions
P E Johnston, J D Morrow, R A Branch
Analytical Biochemistry
|
January 1, 1990
Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids
J D Morrow, T M Harris, L J Roberts
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners
|
July 4, 1998
Infants with Down syndrome: a look at temperament
C F Zickler, J D Morrow, M J Bull
Clinical Pharmacology and Therapeutics
|
April 1, 1995
Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo
C D Downard, L J Roberts, J D Morrow
Prostaglandins
|
October 1, 1994
Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor
A W Longmire, L J Roberts, J D Morrow
Journal of Biomedical Science
|
July 27, 1999
The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid
T Liu, A Stern, L J Roberts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 31, 1997
Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions
C Gniwotta, J D Morrow, L J Roberts, et al.
Page
of 18